翰森制药委任黄浣琪为联席公司秘书、授权代表及法律程序文件代理人

格隆汇资讯
24 Jan

格隆汇1月24日丨翰森制药(03692.HK)宣布,谭思慧由于个人工作安排已辞任公司的联席公司秘书,及不再担任香港联合交易所有限公司证券上市规则第3.05条项下的公司授权代表("授权代表")以及上市规则第19.05(2)条及公司条例(香港法例第622章)第16部项下所规定代表公司于香港接收法律程序文件及通知的公司授权代表("法律程序文件代理人"),自2025年1月24日起生效。继谭思慧辞任后,...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10